Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU)
Historical Holders from Q4 2024 to Q3 2025
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Symbol
-
TDACU on Nasdaq
-
Shares outstanding
-
17,264,276
-
Price per share
-
$10.40
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
1,509,117
-
Holdings value
-
$15,804,316
-
% of all portfolios
-
0%
-
Share change
-
-881,766
-
Value change
-
-$9,094,416
-
Average buys %
-
+0%
-
Average sells %
-
-0%
-
Number of holders
-
7
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
Magnetar Financial LLC
|
7.5%
|
|
$13,182,000
|
|
1,300,000
|
|
MAGNETAR FINANCIAL LLC
|
31 Dec 2024
|
As of 30 Sep 2025, Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) has 7 institutional shareholders filing 13F forms.
They hold 1,509,117 shares
of 17,264,276 outstanding shares (8.7%)
.
Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) across Reporting Periods
| Period |
Reported Shares, Excl. Options |
Value, Excl. Options |
Value Change |
Puts Notional Value |
Calls Notional Value |
Price |
Investors |
|
2025 Q3
|
1,509,117 |
$15,804,316 |
-$9,094,416 |
|
|
$10.40 |
7 |
|
2025 Q2
|
2,390,883 |
$24,722,130 |
-$18,828,233 |
|
|
$10.30 |
9 |
|
2025 Q1
|
4,407,963 |
$44,695,553 |
-$106,490,199 |
|
|
$10.14 |
21 |
|
2024 Q4
|
15,028,755 |
$150,646,354 |
+$149,794,673 |
|
|
$10.02 |
42 |